Chemed Holds Annual Stockholders Meeting on Key Decisions

Chemed ( (CHE) ) has issued an announcement.

On May 19, 2025, Chemed Corporation held its annual meeting of stockholders where several key decisions were made. The entire Board of Directors was elected, the 2025 Stock Incentive Plan was approved, and PricewaterhouseCoopers LLP was ratified as the company’s independent accountants for the year ending December 31, 2024. Additionally, the executive compensation program was approved on a non-binding basis. A proposal to reduce the stockholder threshold for calling a special meeting was not presented due to the absence of the proponent or a representative.

The most recent analyst rating on (CHE) stock is a Buy with a $708.00 price target. To see the full list of analyst forecasts on Chemed stock, see the CHE Stock Forecast page.

Spark’s Take on CHE Stock

According to Spark, TipRanks’ AI Analyst, CHE is a Outperform.

Chemed’s overall stock score reflects its strong financial performance and robust growth prospects, particularly within its VITAS segment. However, challenges in Roto Rooter’s EBITDA and valuation concerns weigh on the score. The technical analysis suggests stable market conditions, with no strong momentum in either direction. The earnings call highlighted growth opportunities but also noted potential risks in revenue management and contractor performance.

To see Spark’s full report on CHE stock, click here.

More about Chemed

Average Trading Volume: 134,975

Technical Sentiment Signal: Buy

Current Market Cap: $8.46B

Learn more about CHE stock on TipRanks’ Stock Analysis page.